Loading...

Andrew Goddard, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentDean's Office
Address155 N Fresno St
Fresno CA 93701
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Andrew Goddard M.D.
    Professor, UCSF

    Dr. Goddard completed his undergraduate and medical degrees at the University of Melbourne in Australia. He completed his residency at Mount Sinai Medical Center and a postdoctoral fellowship at Yale University. Dr. Goddard is board certified in Psychiatry.


    Collapse Research 
    Collapse Research Activities and Funding
    GABA NEURONAL DYSFUNCTION IN PANIC DISORDER
    NIH/NIMH R01MH058657Aug 15, 1999 - Jul 31, 2001
    Role: Principal Investigator
    NEURONAL INTERACTIONS IN THE SRI TREATMENT OF PANIC
    NIH/NIMH K08MH001322Sep 30, 1996 - Apr 30, 2001
    Role: Principal Investigator
    MODULATION BY 5-HT OF NE FUNCTION IN PANIC DISORDER
    NIH/NIMH R03MH050641Apr 1, 1993 - Mar 31, 1995
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Goddard AW, Schwartz K, Hendrix K, Aalsma MC, Slaven J, Hancock EF, Lambert D, Downs S, Rosenman M. Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012. Psychiatr Serv. 2016 Sep 01; 67(9):1030-4. PMID: 27181731.
      View in: PubMed
    2. Goddard AW. Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications. World J Psychiatry. 2016 Mar 22; 6(1):43-53. PMID: 27014597; PMCID: PMC4804267.
    3. Goddard AW, Mahmud W, Medlock C, Shin YW, Shekhar A. A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Ann Gen Psychiatry. 2015; 14:26. PMID: 26379759; PMCID: PMC4570751.
    4. Storch EA, Goddard AW, Grant JE, De Nadai AS, Goodman WK, Mutch PJ, Medlock C, Odlaug B, McDougle CJ, Murphy TK. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32. PMID: 23842022.
      View in: PubMed
    5. Shin YW, Dzemidzic M, Jo HJ, Long Z, Medlock C, Dydak U, Goddard AW. Increased resting-state functional connectivity between the anterior cingulate cortex and the precuneus in panic disorder: resting-state connectivity in panic disorder. J Affect Disord. 2013 Sep 25; 150(3):1091-5. PMID: 23688914; PMCID: PMC3759545.
    6. Long Z, Medlock C, Dzemidzic M, Shin YW, Goddard AW, Dydak U. Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 01; 44:131-5. PMID: 23391588; PMCID: PMC3758115.
    7. Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv. 2011 Sep; 62(9):1032-40. PMID: 21885581.
      View in: PubMed
    8. Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety. 2010 May; 27(5):417-25. PMID: 20455246.
      View in: PubMed
    9. Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety. 2010 Apr; 27(4):339-50. PMID: 19960531.
      View in: PubMed
    10. Stein M, Steckler T, Lightfoot JD, Hay E, Goddard AW. Pharmacologic treatment of panic disorder. Curr Top Behav Neurosci. 2010; 2:469-85. PMID: 21309122.
      View in: PubMed
    11. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Träskman-Bendz L, Goddard AW, Brundin L, Shekhar A. A key role for orexin in panic anxiety. Nat Med. 2010 Jan; 16(1):111-5. PMID: 20037593; PMCID: PMC2832844.
    12. Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today. 2008 Apr; 13(7-8):325-32. PMID: 18405845.
      View in: PubMed
    13. Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet. 2006 Apr; 78(4):543-53. PMID: 16532386; PMCID: PMC1424685.
    14. Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. J Clin Psychiatry. 2005 Jan; 66(1):94-9. PMID: 15669894.
      View in: PubMed
    15. Goddard AW, Mason GF, Appel M, Rothman DL, Gueorguieva R, Behar KL, Krystal JH. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry. 2004 Dec; 161(12):2186-93. PMID: 15569888.
      View in: PubMed
    16. Gelernter J, Liu X, Hesselbrock V, Page GP, Goddard A, Zhang H. Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking. Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 01; 128B(1):94-101. PMID: 15211640.
      View in: PubMed
    17. Goddard AW, Mason GF, Rothman DL, Behar KL, Petroff OA, Krystal JH. Family psychopathology and magnitude of reductions in occipital cortex GABA levels in panic disorder. Neuropsychopharmacology. 2004 Mar; 29(3):639-40. PMID: 14973435.
      View in: PubMed
    18. Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S, Pauls DL, Goodson S. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet. 2001 Aug 08; 105(6):548-57. PMID: 11496373.
      View in: PubMed
    19. Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res. 2001 Aug 05; 103(1):1-14. PMID: 11472786.
      View in: PubMed
    20. Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry. 2001 Jul; 58(7):681-6. PMID: 11448376.
      View in: PubMed
    21. Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OA, Charney DS, Krystal JH. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry. 2001 Jun; 58(6):556-61. PMID: 11386984.
      View in: PubMed
    22. Krystal JH, D'Souza DC, Sanacora G, Goddard AW, Charney DS. Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Med Clin North Am. 2001 May; 85(3):559-77. PMID: 11349473.
      View in: PubMed
    23. Jetty PV, Charney DS, Goddard AW. Neurobiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001 Mar; 24(1):75-97. PMID: 11225510.
      View in: PubMed
    24. Powell J, Bray J, Roberts H, Goddard A, Smith E. Goal negotiation with older people in three day care settings. Health Soc Care Community. 2000 Nov; 8(6):380-389. PMID: 11560708.
      View in: PubMed
    25. Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, Staib L, Stern E, Cappiello A, Woods S, Baldwin R, Charney DS. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry. 2000 Jan 15; 47(2):96-106. PMID: 10664825.
      View in: PubMed
    26. Goddard AW, Woods SW, Money R, Pande AC, Charney DS, Goodman WK, Heninger GR, Price LH. Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder. Psychiatry Res. 1999 Mar 22; 85(3):225-40. PMID: 10333376.
      View in: PubMed
    27. Grilo CM, Money R, Barlow DH, Goddard AW, Gorman JM, Hofmann SG, Papp LA, Shear MK, Woods SW. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry. 1998 Nov-Dec; 39(6):323-32. PMID: 9829138.
      View in: PubMed
    28. Woods SW, Sholomskas DE, Shear MK, Gorman JM, Barlow DH, Goddard AW, Cohen J. Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions. Am J Psychiatry. 1998 Oct; 155(10):1446-8. PMID: 9766781.
      View in: PubMed
    29. Goddard AW, Charney DS. SSRIs in the treatment of panic disorder. Depress Anxiety. 1998; 8 Suppl 1:114-20. PMID: 9809223.
      View in: PubMed
    30. Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry. 1997; 58 Suppl 2:4-11; discussion 11-2. PMID: 9078988.
      View in: PubMed
    31. Goddard AW, Narayan M, Woods SW, Germine M, Kramer GL, Davis LL, Petty F. Plasma levels of gamma-aminobutyric acid and panic disorder. Psychiatry Res. 1996 Jul 31; 63(2-3):223-5. PMID: 8878319.
      View in: PubMed
    32. Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry. 1995 Jul 15; 38(2):74-85. PMID: 7578653.
      View in: PubMed
    33. Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. Effects of tryptophan depletion in panic disorder. Biol Psychiatry. 1994 Dec 01; 36(11):775-7. PMID: 7858076.
      View in: PubMed
    34. Germine M, Goddard AW, Sholomskas DE, Woods SW, Charney DS, Heninger GR. Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage. Psychiatry Res. 1994 Nov; 54(2):115-33. PMID: 7761547.
      View in: PubMed
    35. Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder. Psychiatry Res. 1993 Aug; 48(2):119-33. PMID: 8416022.
      View in: PubMed
    36. Seibyl JP, Woods SW, Zoghbi SS, Baldwin RM, Dey HM, Goddard AW, Zea-Ponce Y, Zubal G, Germine M, Smith EO. Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM. J Nucl Med. 1992 Nov; 33(11):1964-71. PMID: 1432157.
      View in: PubMed
    37. Zoghbi SS, Baldwin RM, Seibyl JP, al-Tikriti MS, Zea-Ponce Y, Laruelle M, Sybirska EH, Woods SW, Goddard AW, Malison RT. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. Int J Rad Appl Instrum B. 1992 Nov; 19(8):881-8. PMID: 1330992.
      View in: PubMed
    38. Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR. Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry. 1992 Sep 01; 32(5):457-61. PMID: 1486151.
      View in: PubMed
    39. Woods SW, Seibyl JP, Goddard AW, Dey HM, Zoghbi SS, Germine M, Baldwin RM, Smith EO, Charney DS, Heninger GR. Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects. Psychiatry Res. 1992 Aug; 45(2):67-77. PMID: 1336860.
      View in: PubMed
    Andrew's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _